Evidence map›Paper›PMID 38660744›Full record

ArticleJournal of clinical periodontology2025

Probing the salivary proteome for prognostic biomarkers in response to non-surgical periodontal therapy.

Angelika Silbereisen, Kai Bao, Witold Wolski, Paolo Nanni, Laura Kunz, Beral Afacan, Gülnur Emingil, Nagihan Bostanci

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical periodontology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Salivary antibody responses toJournal of advanced periodontology & implant dentistry · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Angelika SilbereisenDivision of Oral Health and Periodontology, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-3717-6969
Kai BaoDivision of Oral Health and Periodontology, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-1183-5607
Witold WolskiFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Paolo NanniFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Laura KunzFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Beral AfacanDepartment of Periodontology, Faculty of Dentistry, Adnan Menderes University, Aydın, Turkey.
Gülnur EmingilDepartment of Periodontology, School of Dentistry, Ege University, İzmir, Turkey.
Nagihan BostanciDivision of Oral Health and Periodontology, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-6742-3556
Karolinska Institutet · SEUniversity of Zurich · CHAdnan Menderes University · TREge University · TR

Funding

Steering Group for Dental Research (SOF)/Region Stockholm (SLL) FoUI-966140Steering Group for Dental Research (SOF)/Region Stockholm (SLL) FoUI-990869Swedish Research Council (Vetenskapsrådet) 2021-03528
6 · The paper itself

Abstract

aimThis prospective study investigated the salivary proteome before and after periodontal therapy. MATERIALS AND

methodsTen systemically healthy, non-smoking, stage III, grade C periodontitis patients underwent non-surgical periodontal treatment. Full-mouth periodontal parameters were measured, and saliva (n = 30) collected pre- (T0), and one (T1) and six (T6) months post-treatment. The proteome was investigated by label-free quantitative proteomics. Protein expression changes were modelled over time, with significant protein regulation considered at false discovery rate <0.05.

resultsTreatment significantly reduced bleeding scores, percentages of sites with pocket depth ≥5 mm, plaque and gingival indexes. One thousand seven hundred and thirteen proteins were identified and 838 proteins (human = 757, bacterial = 81) quantified (≥2 peptides). At T1, 80 (T1 vs. T0: 60↑:20↓), and at T6, 118 human proteins (T6 vs. T0: 67↑:51↓) were regulated. The salivary proteome at T6 versus T1 remained stable. Highest protein activity post- versus pre-treatment was observed for cellular movement and inflammatory response. The small proline-rich protein 3 (T1 vs. T0: 5.4-fold↑) and lymphocyte-specific protein 1 (T6 vs. T0: 4.6-fold↓) were the top regulated human proteins. Proteins from Neisseria mucosa and Treponema socranskii (T1 vs. T0: 8.0-fold↓, 4.9-fold↓) were down-regulated.

conclusionsPeriodontal treatment reduced clinical disease parameters and these changes were reflected in the salivary proteome. This underscores the potential of utilizing saliva biomarkers as prognostic tools for monitoring treatment outcomes.

Indexed as

BiomarkersProteomeSalivaAdultFemaleHumansMaleMiddle AgedPeriodontal IndexPeriodontitisPrognosisProspective StudiesProteomicsSalivary Proteins and PeptidesBiomarkersProteomeSalivary Proteins and Peptidesbiomarkerslabel‐free quantitative proteomicsperiodontal treatmentperiodontitissalivasubgingival instrumentation

Identifiers

PMID38660744
PMCPMC11671166
OpenAlexW4395465923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.